Atezolizumab Biosimilar - Research Grade

Atezolizumab Biosimilar - Research Grade, Host: Humanized, IgG1 kappa
Artikelnummer
ICH4018-5MG
Verpackungseinheit
5mg
Hersteller
Ichorbio

Verfügbarkeit: wird geladen...
Preis wird geladen...
Target: PD-L1.

Specificity: Detects human PDL-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Atezolizumab.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Atezolizumab biosimilar is an Fc-engineered, humanized, monoclonal antibody that binds to PD-L1 and blocks interactions with the PD-1 and B7.1 receptors. Atezolizumab biosimilar is a non-glycosylated IgG1 kappa immunoglobulin that has a calculated molecular mass of 145 kDa.

Concentration: 1.0 - 5.0 mg/ml.

Formulation: Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

Purity: >95% by SDS-PAGE and HPLC.

Endotoxin: ≤ 0.75 EU/mg as determined by the LAL method.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Mehr Informationen
Artikelnummer ICH4018-5MG
Hersteller Ichorbio
Hersteller Artikelnummer ICH4018-5MG
Verpackungseinheit 5mg
Mengeneinheit STK
Reaktivität Human
Klonalität Monoclonal
Isotyp IgG1 kappa
Wirt Humanized
Produktinformation (PDF) Download
MSDS (PDF) Download